ArticleCancers2025

Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182.

Megan Fife et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.